Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001214659-24-018630
Filing Date
2024-11-08
Accepted
2024-11-08 16:56:15
Documents
1
Group Members
CONCENTRA BIOSCIENCES, LLCKEVIN TANGTANG CAPITAL PARTNERS III, INCTANG CAPITAL PARTNERS IV, INCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 e117241sc13d.htm SC 13D 120298
  Complete submission text file 0001214659-24-018630.txt   122103
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

EIN.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-88939 | Film No.: 241441522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)